Iwaki Seiyaku Co., Ltd. entered into an agreement to acquire Sakura Plant from Torii Pharmaceutical Co., Ltd. (TSE:4551) for ¥1.1 billion on March 18, 2019. Employment of the employees currently working for Sakura Plant will be maintained under IWAKI. Torii’s products will be continuously manufactured in Sakura Plant for a stable supply. The transaction has been approved by the Board of Directors of Torii Pharmaceutical Co., Ltd. on March 18, 2020. The transaction is expected to complete on July 1, 2020. The effects of the transaction on the business performance of Torii’s in this fiscal year will be immaterial. Iwaki Seiyaku Co., Ltd. completed the acquisition of Sakura Plant from Torii Pharmaceutical Co., Ltd. (TSE:4551) on July 1, 2020.